Rami Jean Salib

Rami Jean Salib

Auto-generated profile, based on publicly available information

Rami Jean Salib

University of Southampton, Faculty of Medicine, Southampton, Hampshire SO16 6YD, UK

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Molecular Therapy
Verified
Journal Article
Open access
RHRobert P. Howlin
Robert P. Howlin
KCKatrina Cathie
Katrina Cathie
LHLuanne Hall-Stoodley
Luanne Hall-Stoodley
VCVictoria Cornelius
Victoria Cornelius
CDCaroline Duignan
Caroline Duignan
JWJeremy S. Webb
Jeremy S. Webb
Despite aggressive antibiotic therapy, bronchopulmonary colonization by Pseudomonas aeruginosa causes persistent morbidity and mortality in cystic fibrosis (CF). Chronic P. aeruginosa infection in the CF lung is associated with structured, antibiotic-tolerant bacterial aggregates known as biofilms. We have demonstrated the effects of non-bactericidal, low-dose nitric oxide (NO), a signaling molecule that induces biofilm dispersal, as a novel adjunctive therapy for P. aeruginosa biofilm infection in CF in an ex vivo model and a proof-of-concept double-blind clinical trial. Submicromolar NO concentrations alone caused disruption of biofilms within ex vivo CF sputum and a statistically significant decrease in ex vivo biofilm tolerance to tobramycin and tobramycin combined with ceftazidime. In the 12-patient randomized clinical trial, 10 ppm NO inhalation caused significant reduction in P. aeruginosa biofilm aggregates compared with placebo across 7 days of treatment. Our results suggest a benefit of using low-dose NO as adjunctive therapy to enhance the efficacy of antibiotics used to treat acute P. aeruginosa exacerbations in CF. Strategies to induce the disruption of biofilms have the potential to overcome biofilm-associated antibiotic tolerance in CF and other biofilm-related diseases.

1 January 2003 in Drug Safety
Verified
Journal Article
Closed access
PDF file
RSRami Jean Salib
Rami Jean Salib
PHPeter Hugo Howarth
Peter Hugo Howarth

1 August 2003 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
RSR.J. Salib
R.J. Salib
ADA. Drake-Lee
A. Drake-Lee
PHP.H. Howarth
P.H. Howarth

1 July 2011 in American Journal of Rhinology & Allergy
Verified
Journal Article
Closed access
FSFranziska A. Stressmann
Franziska A. Stressmann
GRGeraint B. Rogers
Geraint B. Rogers
SCSamuel W. Chan
Samuel W. Chan
PHPeter H. Howarth
Peter H. Howarth
PHPhilip G. Harries
Philip G. Harries
RSRami J. Salib
Rami J. Salib
Background: Chronic rhinosinusitis (CRS) with or without polyps is a common chronic upper airway condition of multifactorial origin. Fundamental to effective treatment of any infection is the ability to accurately characterize the underlying cause. Many studies have shown that only a small fraction of the total range of bacterial species present in CRS is detected through conventional culture-dependent techniques. Consequently, culture data are often unrepresentative of the true diversity of the microbial community within the sample. These drawbacks, along with the length of time required to complete the analysis, strongly support the development of alternative means of assessing which bacterial species are present. As such, molecular microbiological approaches that assess the content of clinical samples in a culture-independent manner could significantly enhance the range and quality of data obtained routinely from such samples. We aimed to characterize the bacterial diversity present in tissue and mucus samples taken from the CRS setting using molecular nonculture-dependent techniques. Methods: Through 16S ribosomal RNA (rRNA) gene clone sequencing and terminal restriction fragment length polymorphism (T-RFLP) analysis, the bacteria present in 70 clinical samples from 43 CRS patients undergoing endoscopic sinus surgery were characterized. Results: Bacterial T-RFLP profiles were generated for 70 of 73 samples and a total of 48 separate bands were detected. Species belonging to 34 genera were identified as present by clone sequence analysis. Of the species detected, those within the genera Pseudomonas, Citrobacter, Haemophilus, Propionibacterium, Staphylococcus, and Streptococcus were found numerically dominant, with Pseudomonas aeruginosa the most frequently detected species. Conclusion: This study has validated the use of the culture-independent technique T-RFLP in sinonasal samples. Preliminary characterization of the microbial diversity in CRS suggests a complex range of common and novel bacterial species within the upper airway in CRS, providing further evidence for the polymicrobial etiology of CRS.

9 December 2003 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
RSR. J. Salib
R. J. Salib
PHP. H. Howarth
P. H. Howarth

14 January 2008 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
RSR. J. Salib
R. J. Salib
PHP. G. Harries
P. G. Harries
SNS. B. Nair
S. B. Nair
PHP. H. Howarth
P. H. Howarth